Timo Vesikari | Charles Explorer

Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials

2013 | Publikace bez příslušnosti k fakultě